| Financial Year |
March 31 2023 |
| Monetary Funds |
231,400,923.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
12,057,526.34 |
| Advances to Suppliers |
5,668,094.41 |
| Other Receivables |
33,719,771.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,112,720.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
5,221,814.65 |
| Other Current Assets |
5,877,678.54 |
| Total Current Assets |
301,058,529.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
23,446,219.08 |
| Long-term Equity Investment |
132,354,860.19 |
| Investment Properties |
54,504,937.51 |
| Fixed Assetes |
959,858,480.49 |
| Under-construction Projects |
60,480,566.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
1,330,277.00 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
99,679,967.33 |
| R&D expenses |
-- |
| Goodwill |
116,844,591.85 |
| Long-Term Deferred and Prepaid Expenses |
7,123,503.96 |
| Deferred Income Tax Assets |
21,348,590.36 |
| Other Non-Current Assets |
8,185,000.24 |
| Sub-Total of Non-Current Assets |
1,577,339,785.76 |
| Total Assets |
1,878,398,315.74 |
| Short-Term Loans |
220,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
4,250,048.71 |
| Accounts Received In Advance |
2,502,219.39 |
| Employee Compensation Payable |
33,966,670.97 |
| Taxes Payable |
13,759,248.84 |
| Interest Payable |
733,951.06 |
| Dividend Payable |
10,962,311.67 |
| Other payables |
133,560,917.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
75,905,673.72 |
| Other Current Liabilities |
186,996.61 |
| Sub-Total of Current Liabilities |
496,406,427.94 |
| Long-term Loans |
86,524,035.52 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
17,526,763.09 |
| Deferred Income Tax Liabilities |
27,037,913.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
191,322,142.65 |
| Total Liabilities |
687,728,570.59 |
| Paid-In Capital(Or Share Stock) |
177,301,325.00 |
| Capital Surplus |
837,435,047.54 |
| Surplus Reserve |
77,927,225.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
70,918,347.69 |
| Minority Stockholder's Interest |
33,829,846.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,156,839,898.99 |
| Owner's Equity（Stockholder's Equity） |
1,190,669,745.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,878,398,315.74 |
